The Dow Chemical Company Release: DOW-COLORCON Controlled Release Alliance Launches METHOCEL™ DC2 To Help Reduce Development Time And Lower Manufacturing Costs At The 2013 American Association of Pharmaceutical Scientists Annual Meeting and Expo

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN ANTONIO--(BUSINESS WIRE)--Dow Pharma & Food Solutions, a business unit of The Dow Chemical Company (NYSE: DOW) and Colorcon Inc., will present the next-generation METHOCEL™ DC2 polymer at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Expo in San Antonio, Texas from November 10 to 14, 2013. Designed to help the pharmaceutical industry shorten development time and lower manufacturing costs, the DOW-COLORCON Controlled Release Alliance supports pharmaceutical manufactures looking to switch to roller compaction and direct compression for matrix tablet applications.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC